21-(ACETYLOXY)-9-BROMO-11-(FORMYLOXY)-17-HYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE, (11.BETA.,16.BETA.)-
UNII B3Q6GYM7CT
Substance Identification & Data
This profile provides standardized clinical and technical data for 21-(acetyloxy)-9-bromo-11-(formyloxy)-17-hydroxy-16-methylpregna-1,4-diene-3,20-dione, (11.beta.,16.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B3Q6GYM7CT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1564242-51-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C25H31BrO7 RNRGHMHDVGMZFQ-AFECKEALSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 21-(acetyloxy)-9-bromo-11-(formyloxy)-17-hydroxy-16-methylpregna-1,4-diene-3,20-dione, (11.beta.,16.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.